Universe Pharmaceuticals will acquire Best Praise International in a $10.75M all-stock transaction involving 4.38M class A shares.
Universe Pharmaceuticals (UPC) agreed to acquire Best Praise International for $10.75M, settling the deal with 4.38M of its class A ordinary shares. The transaction grants UPC full ownership of Best Praise’s issued shares.
The acquisition marks UPC’s latest expansion move, though no prior valuation or consensus estimates were disclosed. The deal structure avoids cash outlay, relying entirely on equity issuance.
No immediate market reaction was reported following the announcement.